Kohichiroh Yasui
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer.
Journal: Japanese journal of clinical oncology
Published: May 01, 2022
Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach.
Journal: Scientific reports
Published: March 03, 2021
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
Journal: Journal of gastroenterology
Published: August 26, 2020
SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma.
Journal: Oncology letters
Published: June 24, 2020
PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
Journal: Scientific reports
Published: May 22, 2020
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).
Journal: International journal of clinical oncology
Published: April 11, 2020
Procedure of Direct Hepatic Artery Puncture for the Treatment of Hepatocellular Carcinoma: Two Case Reports.
Journal: Case reports in oncology
Published: February 04, 2020
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey.
Journal: Journal of gastroenterology
Published: August 06, 2019
Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: May 16, 2019
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: December 21, 2018
Last Updated: 09/26/2026